MedPath

Chloroprocaine

Generic Name
Chloroprocaine
Brand Names
Clorotekal, Iheezo, Nesacaine
Drug Type
Small Molecule
Chemical Formula
C13H19ClN2O2
CAS Number
133-16-4
Unique Ingredient Identifier
5YVB0POT2H

Overview

Chloroprocaine is an ester local anesthetic commonly available in its salt form, chloroprocaine hydrochloride. Similar to other local anesthetics, it increases the threshold for electrical excitation in nerves by slowing the propagation of the nerve impulse and reducing the rate of rise of the action potential. The pharmacological profile of chloroprocaine is characterized by a short latency and duration, similar to the one observed with lidocaine. Chloroprocaine can be given as an injection, and is available in formulations with and without methylparaben as a preservative. Both can be given as intrathecal injections for peripheral and central nerve block, but only the preservative-free formulation can be used for lumbar and caudal epidural blocks. Topical chloroprocaine for ophthalmic use was approved by the FDA in September 2022 for ocular surface anesthesia.

Background

Chloroprocaine is an ester local anesthetic commonly available in its salt form, chloroprocaine hydrochloride. Similar to other local anesthetics, it increases the threshold for electrical excitation in nerves by slowing the propagation of the nerve impulse and reducing the rate of rise of the action potential. The pharmacological profile of chloroprocaine is characterized by a short latency and duration, similar to the one observed with lidocaine. Chloroprocaine can be given as an injection, and is available in formulations with and without methylparaben as a preservative. Both can be given as intrathecal injections for peripheral and central nerve block, but only the preservative-free formulation can be used for lumbar and caudal epidural blocks. Topical chloroprocaine for ophthalmic use was approved by the FDA in September 2022 for ocular surface anesthesia.

Indication

Chloroprocaine for intrathecal injection is indicated for the production of subarachnoid block (spinal anesthesia) in adults. It is also indicated for the production of local anesthesia by infiltration, peripheral and central nerve block, and a preservative-free form can also be used for lumbar and caudal epidural blocks. Topical chloroprocaine for ophthalmic use is indicated for ocular surface anesthesia.

Associated Conditions

No associated conditions information available.

FDA Approved Products

Chloroprocaine Hydrochloride
Manufacturer:Hikma Pharmaceuticals USA Inc.
Route:EPIDURAL, INFILTRATION, INTRACAUDAL, PERINEURAL
Strength:30 mg in 1 mL
Approved: 2022/02/25
NDC:0143-9210
Chloroprocaine Hydrochloride
Manufacturer:Hikma Pharmaceuticals USA Inc.
Route:EPIDURAL, INFILTRATION, INTRACAUDAL, PERINEURAL
Strength:20 mg in 1 mL
Approved: 2022/02/25
NDC:0143-9209
Nesacaine
Manufacturer:Fresenius Kabi USA, LLC
Route:INFILTRATION, PERINEURAL
Strength:20 mg in 1 mL
Approved: 2022/09/01
NDC:63323-476
CHLOROPROCAINE HCI
Manufacturer:HF Acquisition Co LLC, DBA HealthFirst
Route:INFILTRATION, PERINEURAL
Strength:20 mg in 1 mL
Approved: 2024/01/22
NDC:51662-1401
Nesacaine MPF
Manufacturer:Fresenius Kabi USA, LLC
Route:INFILTRATION, PERINEURAL, INTRACAUDAL, EPIDURAL
Strength:20 mg in 1 mL
Approved: 2022/09/01
NDC:63323-477

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath